ConductScience.org, home

Paper80634

Innappropriate renin secretion unmasked by captopril (SQ 14 225) in hypertension of chronic renal failure.

Brunner HR and 5 others. Lancet, 1978. Cited by 98 papers, by iCite.

Cite this record

ConductScience Library. Innappropriate renin secretion unmasked by captopril (SQ 14 225) in hypertension of chronic renal failure. Papers, record 80634. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/80634

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Innappropriate renin secretion unmasked by captopril (SQ 14 225) in hypertension of chronic renal failure.
PubMed
Journal
Lancet
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
98
iCite
Relative citation ratio, by iCite
5.01
iCite
Revised in PubMed
2019-06-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brunner HRH R
2Waeber BB
3Wauters JPJ P
4Turin GG
5McKinstry DD
6Gavras HH

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Angiotensin-Converting Enzyme InhibitorsMajor topic
Antihypertensive AgentsMajor topic
Hypertension, RenalMajor topic
Kidney Failure, ChronicMajor topic
ProlineMajor topic
ReninMajor topic
Administration, Oral
Adult
Blood Pressure
Drug Therapy, Combination
Female
Furosemide
Humans
Male
Middle Aged
Sodium

Source PubMed

Download CSV of topics

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.

PMIDTitleJournalYearIn PapersSource
32379896Knowledge-based structural models of SARS-CoV-2 proteins and their complexes with potential drugs.FEBS Lett2020https://conductscience.org/library/papers/32379896PubMed
30112656Should ACE inhibitors and ARBs be used in combination in children?Pediatr Nephrol2019https://conductscience.org/library/papers/30112656PubMed
7873092Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction.Drug Saf1994https://conductscience.org/library/papers/7873092PubMed
7017137Captopril for refractory hypertension in patients with chronic renal failure and renal transplantation.J R Soc Med1981https://conductscience.org/library/papers/7017137PubMed
7009848Concepts in hypertension. The Croonian Lecture 1979.J R Coll Physicians Lond1980https://conductscience.org/library/papers/7009848PubMed
7009133Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy.Drugs1980https://conductscience.org/library/papers/7009133PubMed
7000102
Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.
Br Heart J1980https://conductscience.org/library/papers/7000102PubMed
6986949Effects of an angiotensin-converting enzyme inhibitor (captopril) on blood pressure in anephric subjects.Br Med J1980https://conductscience.org/library/papers/6986949PubMed
6802291Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol.Br Med J (Clin Res Ed)1982https://conductscience.org/library/papers/6802291PubMed
6750588Low dose captopril in the treatment of severe refractory hypertension associated with renal failure.Postgrad Med J1982https://conductscience.org/library/papers/6750588PubMed
6428648Reversible acute on chronic renal failure during captopril treatment.Br Med J (Clin Res Ed)1984https://conductscience.org/library/papers/6428648PubMed
6164426Angiotensin converting enzyme inhibition: a new therapeutic modality.Bull N Y Acad Med1981https://conductscience.org/library/papers/6164426PubMed
3023783Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.Med Toxicol1986https://conductscience.org/library/papers/3023783PubMed
3015637Intra-individual comparison of captopril and enalapril in patients undergoing regular haemodialysis.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3015637PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ACE1636PubTator's text mininghttps://conductscience.org/library/genes/1636NCBI Gene
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/80634

GET https://conductscience.org/api/papers/v1/80634/authors